SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-12-067391
Filing Date
2012-12-11
Accepted
2012-12-11 15:42:42
Documents
2
Group Members
BEN T. MORRISDON A. SANDERSDONALD V. WEIRJAMES C. GALEJOYCE ERONYLIFE SCIENCES OPPORTUNITIES FUND (INSTITUTIONAL) II, L.P.SIGNET HEALTHCARE PARTNERS, LLCSMW INVESTMENTS I, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 v330074_sc13da.htm SC 13D/A 198025
2 JOINT FILING AGREEMENT v330074_ex1.htm EX-1 9773
  Complete submission text file 0001144204-12-067391.txt   209757
Mailing Address 105 LINCOLN AVENUE BUENA NJ 08310
Business Address 105 LINCOLN AVENUE BUENA NJ 08310 6096971441
IGI LABORATORIES, INC (Subject) CIK: 0000352998 (see all company filings)

IRS No.: 010355758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-34057 | Film No.: 121256113
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 126 E 56TH STREET 28TH FL NEW YORK NY 10022
Business Address 126 EAST 56TH STREET NEW YORK NY 10022 212-419-3900
LIFE SCIENCES OPPORTUNITIES FUND II LP (Filed by) CIK: 0001269415 (see all company filings)

IRS No.: 571190948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A